###begin article-title 0
Duplication and selection in the evolution of primate beta-defensin genes
###end article-title 0
###begin p 1
###xml 176 181 <span type="species:ncbi:9606">human</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
Peptides such as beta-defensins are an important component in innate immunity. A combination of laboratory and computational techniques have been used to characterize the main human beta-defensin locus on chromosome 8p22-p23. The genomic structures and expression patterns of four novel human beta-defensin genes and a related pseudogene reveal prior duplication events and selection.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 564 569 <span type="species:ncbi:9606">human</span>
###xml 676 681 <span type="species:ncbi:9606">human</span>
###xml 833 838 <span type="species:ncbi:9606">human</span>
Innate immunity is the first line of defense against microorganisms in vertebrates and acts by providing an initial barrier to microorganisms and triggering adaptive immune responses. Peptides such as beta-defensins are an important component of this defense, providing a broad spectrum of antimicrobial activity against bacteria, fungi, mycobacteria and several enveloped viruses. beta-defensins are small cationic peptides that vary in their expression patterns and spectrum of pathogen specificity. Disruptions in beta-defensin function have been implicated in human diseases, including cystic fibrosis, and a fuller understanding of the variety, function and evolution of human beta-defensins might form the basis for novel therapies. Here we use a combination of laboratory and computational techniques to characterize the main human beta-defensin locus on chromosome 8p22-p23.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 112 117 <span type="species:ncbi:9606">human</span>
In addition to known genes in the region we report the genomic structures and expression patterns of four novel human beta-defensin genes and a related pseudogene. These genes show an unusual pattern of evolution, with rapid divergence between second exon sequences that encode the mature beta-defensin peptides matched by relative stasis in first exons that encode signal peptides.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 221 226 <span type="species:ncbi:9606">human</span>
###xml 227 233 <span type="species:ncbi:9557">baboon</span>
We conclude that the 8p22-p23 locus has evolved by successive rounds of duplication followed by substantial divergence involving positive selection, to produce a diverse cluster of paralogous genes established before the human-baboon divergence more than 23 million years ago. Positive selection, disproportionately favoring alterations in the charge of amino-acid residues, is implicated as driving second exon divergence in these genes.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 683 684 666 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 685 686 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 573 578 <span type="species:ncbi:9606">human</span>
###xml 715 720 <span type="species:ncbi:9606">human</span>
###xml 791 796 <span type="species:ncbi:9606">human</span>
The vertebrate innate immune system provides protection against a wide range of pathogenic microorganisms, and defensins are an important component of this response as well as having a role in adaptive immunity. In mammals, the defensins can be divided into the alpha- and beta-defensin subfamilies on the basis of differences in the spacing of six, conserved cysteine residues. The alpha-defensins are produced by neutrophils and intestinal Paneth cells, whereas the beta-defensins are mainly produced by epithelial cells in contact with the environment. The functions of human beta-defensins seem to be disrupted in cystic fibrosis and inflammatory skin lesions such as psoriasis [1,2]. A fuller knowledge of the human complement of beta-defensins may therefore be useful in understanding human disease as well as in the design of novel, synthetic antimicrobial peptides.
###end p 9
###begin p 10
###xml 271 272 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 439 440 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 610 615 598 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1</italic>
###xml 625 631 613 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB4 </italic>
###xml 641 646 629 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB2</italic>
###xml 657 665 645 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB103 </italic>
###xml 675 680 663 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB3</italic>
###xml 694 702 682 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104 </italic>
###xml 712 717 700 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB4</italic>
###xml 846 852 834 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 970 976 958 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB4 </italic>
###xml 1309 1318 1297 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1319 1320 1307 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1561 1583 1546 1568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus </italic>
###xml 1613 1621 1598 1606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104 </italic>
###xml 1825 1848 1810 1833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas aeruginosa </italic>
###xml 1851 1876 1836 1861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae </italic>
###xml 1877 1878 1862 1863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 340 345 <span type="species:ncbi:9606">human</span>
###xml 350 355 <span type="species:ncbi:10090">mouse</span>
###xml 388 393 <span type="species:ncbi:9606">human</span>
###xml 417 422 <span type="species:ncbi:10090">mouse</span>
###xml 466 471 <span type="species:ncbi:9606">human</span>
###xml 585 590 <span type="species:ncbi:9606">human</span>
###xml 1561 1582 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 1825 1847 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 1851 1875 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
The known human beta-defensin genes show a conserved two-exon structure: the first exon encodes a signal peptide whereas the second exon encodes a short propiece and the mature defensin peptide with a characteristic six-cysteine motif and many basic amino-acid residues [3]. The beta-defensin genes are present at five syntenic loci in the human and mouse genomes, with the main locus on human chromosome 8p22-23 and mouse chromosome 8A3 [4]. All four, full-length, human beta-defensins that are present in the public databases are from 8p22-23 (GenBank sequence accession numbers are human beta-defensin 1 or DEFB1, Q09753; DEFB4 (formerly DEFB2), O15263; DEFB103 (formerly DEFB3), NP_061131; DEFB104 (formerly DEFB4), CAC85520), but there are substantial differences in their coding sequences, expression patterns and antimicrobial activities. DEFB1 is constitutively expressed in many tissues (respiratory tract, kidney, urogenital and oral cavity epithelia) whereas DEFB4 is expressed in response to bacterial infection or proinflammatory agonists in respiratory tract epithelial cells, and epidermal and gingival keratinocytes. Both DEFB1 and DEFB4 proteins have salt-sensitive, bactericidal activity against a spectrum of Gram-positive and Gram-negative enteric, urinary tract, and respiratory bacteria in vitro [5]. DEFB103 is expressed in epithelial cells, adult heart, skeletal muscle, placenta and fetal thymus, it has broad-spectrum antimicrobial activity under conditions of low salt and (unusually among beta-defensins) it retains activity against Staphylococcus aureus even in physiological saline. DEFB104 achieves highest expression in the testis (with lower levels in gastric antrum, neutrophils, uterus, thyroid, lung and kidney) and was found to be inducible in the respiratory epithelium upon exposure to Pseudomonas aeruginosa or Streptococcus pneumoniae [3].
###end p 10
###begin p 11
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 508 509 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 549 551 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 567 573 560 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 626 628 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 485 491 <span type="species:ncbi:9913">bovine</span>
The evolution of various genes involved in the vertebrate immune system has involved duplication followed by selection to provide responses to a wide range of pathogens, with well documented examples in immunoglobulin [6] and major histocompatibility complex genes [7]. Hughes and Yeager [8] studied the evolution of alpha-defensins and found evidence for duplication followed by diversification driven by positive selection. Similar phenomena were also implicated in the evolution of bovine beta-defensins [9] and amphibian antimicrobial peptides [10]. In contrast, DEFB1 was found not to vary significantly across primates [11].
###end p 11
###begin p 12
###xml 224 231 221 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105</italic>
###xml 233 240 230 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB106</italic>
###xml 242 249 239 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107</italic>
###xml 251 258 248 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108</italic>
###xml 285 294 282 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB109p </italic>
###xml 90 95 <span type="species:ncbi:9606">human</span>
Here we describe a combined strategy to identify further beta-defensin genes in the draft human genome sequence using computational techniques and verification using reverse transcription-PCR. Four full-length, novel genes (DEFB105, DEFB106, DEFB107, DEFB108) and a related pseudogene DEFB109p are reported, as well as their expression patterns and evidence for their evolution by duplication and positive selection.
###end p 12
###begin title 13
Results
###end title 13
###begin p 14
###xml 13 15 13 15 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 459 461 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 771 778 759 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPAG11 </italic>
###xml 788 791 776 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EP2</italic>
###xml 799 801 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 835 843 820 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105 </italic>
###xml 847 854 832 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB106</italic>
###xml 1028 1035 1013 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107</italic>
###xml 1037 1045 1022 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108 </italic>
###xml 1049 1057 1034 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB109p</italic>
###xml 1210 1212 1195 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1231 1240 1216 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB109p </italic>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 360 365 <span type="species:ncbi:9606">human</span>
###xml 544 549 <span type="species:ncbi:9606">human</span>
###xml 714 719 <span type="species:ncbi:9606">human</span>
All TBLASTX [12] matches to human bacterial artificial chromosome (BAC) clone sequences were in the 8p22-p23 region in a subsection of FPC contig ctg45 (1 April freeze WashU Accession Map Layout Files [13]) bounded by the BAC clones RP11-161B1 (AC079018) and SCb-177K12 (AF252831) and consisting of 53 BACs in total. These 53 BACs were deemed to represent the human beta-defensin gene family locus and were masked for repetitive sequences using RepeatMasker [14]. This locus was the subject of a more sensitive search for the presence of novel human beta-defensins, using a hidden Markov model constructed from an alignment of the GenBank beta-defensin sequences mentioned above. As well as the known, full-length human beta-defensins and the related epididymis-specific SPAG11 (formerly EP2) gene [15], two novel beta-defensin genes, DEFB105 and DEFB106, were identified in this search and were then incorporated into the previous hidden Markov model. Further searches with this revised model identified a further three genes: DEFB107, DEFB108 and DEFB109p. None of these five genes was found in the EMBL sequence database (24 June 2002 release) or in the Ensembl genomic annotation database (version 6.28.1 [16]). The novel gene DEFB109p appears to be a pseudogene as it contains a premature stop codon within its first exon, as observed in three independently sequenced, overlapping 8p22-p23 BAC sequences (accession numbers AC068974, AC087203 and AF252830). Given the absence of premature stop codons in the other four genes, despite considerable divergence among them (they encode only 18-28% identical amino-acid residues), it is unlikely that they too are pseudogenes.
###end p 14
###begin p 15
###xml 101 106 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 109 110 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 838 843 832 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB5</italic>
###xml 845 850 839 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB6</italic>
###xml 852 857 846 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB7</italic>
###xml 859 865 853 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB8 </italic>
###xml 869 874 863 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB9</italic>
###xml 896 903 890 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 904 905 898 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 980 982 974 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1011 1018 1005 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105</italic>
###xml 1020 1027 1014 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB106</italic>
###xml 1029 1036 1023 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107</italic>
###xml 1038 1046 1032 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108 </italic>
###xml 1050 1059 1044 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB109p </italic>
###xml 1073 1080 1067 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB109</italic>
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
###xml 945 950 <span type="species:ncbi:9606">Human</span>
Many putative final exon fragments from novel mouse beta-defensins were recently reported by Schutte et al. [4]. However, their data were incomplete and were not supported by experimental verification. They used computational techniques to identify sequences matching a central portion of the mature defensin peptide including the six-cysteine motif characteristic of beta-defensins. At best, this method could only identify incomplete final exons encoding this region of the peptide. No attempt was made to delineate precisely the boundaries of final exons or to identify first exons by these authors. In the present study we restrict our attention to complete genes, present in a BAC-clone-based map of the region and verified as encoding real transcripts by RT-PCR. Our full-length novel genes correspond to five final exon fragments (DEFB5, DEFB6, DEFB7, DEFB8 and DEFB9) reported by Schutte et al. [4] and we have adopted the official HUGO Human Gene Nomenclature Committee [17] names for these fragments: DEFB105, DEFB106, DEFB107, DEFB108 and DEFB109p (amended from DEFB109) respectively.
###end p 15
###begin p 16
###xml 295 303 295 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB106 </italic>
###xml 307 314 307 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107</italic>
###xml 533 541 533 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105 </italic>
###xml 732 739 732 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108</italic>
###xml 824 832 824 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108 </italic>
###xml 1354 1362 1354 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108 </italic>
###xml 1462 1464 1459 1461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1597 1605 1594 1602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB109p</italic>
###xml 927 932 <span type="species:ncbi:9606">human</span>
###xml 1331 1336 <span type="species:ncbi:9606">human</span>
###xml 1440 1445 <span type="species:ncbi:9606">human</span>
RT-PCR amplification confirmed the presence of the computationally predicted, functional genes, but sequencing of these products and subsequent alignment to genomic sequence also uncovered several instances where the actual gene structures differed from those that were predicted. In two cases, DEFB106 and DEFB107, splice sites other than those predicted were used and it was found that the predicted coding sequences had been respectively 36 base-pairs (bp) longer and 9 bp shorter than the actual coding sequences. In the case of DEFB105 RT-PCR verified the two predicted exons but also uncovered an additional, 42-bp intervening exon. The RT-PCR analysis also produced interesting results with respect to the coding sequence of DEFB108. In four independent, sequenced RT-PCR products from one mRNA sample, the amplified DEFB108 sequence was consistently found to differ from the computationally predicted sequence from the human public draft sequence at three nucleotide sites, but was otherwise identical. The three differences observed between predicted and amplified sequences respectively were an A to G at nucleotide 62 (which causes a conservative amino-acid change from lysine to arginine), a T to C at nucleotide 111 (which is a synonymous change) and a C to T at nucleotide 120 (also synonymous). This indicates novel human polymorphisms in DEFB108 and is consistent with observations of high degrees of polymorphism for other human beta-defensins [18] (see also Additional data files 1-6 for the novel gene sequences confirmed by RT-PCR and the computationally predicted sequence of DEFB109p).
###end p 16
###begin p 17
###xml 7 9 7 9 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 104 113 104 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB109p </italic>
###xml 151 159 151 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB2-4 </italic>
###xml 195 201 195 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPAG11</italic>
###xml 263 269 263 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 344 346 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 434 436 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 477 482 474 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1</italic>
###xml 702 710 699 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104 </italic>
###xml 718 724 715 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB4 </italic>
###xml 727 734 724 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB103</italic>
###xml 758 765 755 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB106</italic>
###xml 767 775 764 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105 </italic>
###xml 779 786 776 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108</italic>
###xml 881 888 878 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104</italic>
###xml 902 910 899 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105 </italic>
###xml 1015 1023 1012 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105 </italic>
###xml 1266 1267 1260 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 2015 2017 2003 2005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 2229 2230 2217 2218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 2362 2370 2350 2358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108 </italic>
###xml 2391 2392 2379 2380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 2413 2420 2401 2408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108</italic>
###xml 315 320 <span type="species:ncbi:9606">human</span>
###xml 1540 1545 <span type="species:ncbi:9606">human</span>
###xml 1625 1630 <span type="species:ncbi:9606">human</span>
###xml 2066 2071 <span type="species:ncbi:9606">human</span>
###xml 2118 2123 <span type="species:ncbi:9606">human</span>
Figure 1a depicts the relative positions and orientations of the four novel genes, the novel pseudogene DEFB109p and four known genes in the vicinity: DEFB2-4 and the related epididymis-specific SPAG11. This cluster is about 350 kilobases (kb) centromeric of the DEFB1 gene. A phylogenetic tree relating functional human beta-defensins (Figure 1b) reflects the spatial distribution of these genes, with the cluster of genes in Figure 1a appearing to form a clade separate from DEFB1. The simplest explanation for the origin of this cluster is a series of local duplication events followed by substantial divergence. In addition it seems that the four novel functional genes are more closely related to DEFB104 than to DEFB4 or DEFB103. Three of these genes, DEFB106, DEFB105 and DEFB108, encode mature peptides exhibiting the same spacing of conserved cysteine residues as seen in DEFB104, although in DEFB105 there is an extra cysteine residue (amino acid 43) towards the amino-terminal end of the mature peptide. DEFB105 also encodes an unusually long propiece peptide region in the second of its three exons. Strikingly, the DEFB107 protein lacks the first canonical beta-defensin cysteine altogether and instead has a serine residue at the same position (Figure 2). The changes in the number of cysteine residues seen in DEFB105 and DEFB107 are likely to have important functional consequences. The predicted mature peptides for the four novel, functional beta-defensins presented here have a similar proportion of cationic residues to human DEFB104, with higher proportions of anionic residues (10-13%) than are seen in human DEFB1, DEFB4 and DEFB103 (less than 4%). Indeed the pI of DEFB107 and DEFB108 are 6.74 and 6.89 respectively, whereas all other beta-defensins described to date are cationic. This relative increase in anionic residues is expected to affect function, as the action of defensins initially involves interactions between the cationic mature defensin peptides and anionic membrane lipids [19]. Expression analysis for the novel, functional human genes was carried out by RT-PCR on a panel of human RNA samples and the novel gene PCR products were confirmed by hybridization to an internal probe (Figure 3). Expression of all four novel genes was readily detected in testis. A longer exposure period revealed low levels of expression of DEFB108 in the liver (Figure 3, left-hand panel of DEFB108). Expression was not detected in any of the other tissues analyzed.
###end p 17
###begin p 18
###xml 112 119 109 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105</italic>
###xml 121 129 118 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB106 </italic>
###xml 133 140 130 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107</italic>
###xml 156 161 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB4</italic>
###xml 163 171 160 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB103 </italic>
###xml 175 182 172 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104</italic>
###xml 220 245 217 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Papio cynocephalus anubis</italic>
###xml 411 417 408 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB4 </italic>
###xml 621 622 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 206 218 <span type="species:ncbi:9555">olive baboon</span>
###xml 220 245 <span type="species:ncbi:9555">Papio cynocephalus anubis</span>
###xml 379 385 <span type="species:ncbi:9557">baboon</span>
###xml 557 563 <span type="species:ncbi:9557">baboon</span>
###xml 602 607 <span type="species:ncbi:9606">human</span>
###xml 683 689 <span type="species:ncbi:9557">baboon</span>
###xml 715 720 <span type="species:ncbi:9606">human</span>
###xml 800 806 <span type="species:ncbi:9557">baboon</span>
###xml 858 864 <span type="species:ncbi:9557">baboon</span>
###xml 976 988 <span type="species:ncbi:9555">olive baboon</span>
###xml 1036 1041 <span type="species:ncbi:9606">human</span>
Six genes highly similar (85-98% identical at the amino-acid level) to three of the novel human beta-defensins (DEFB105, DEFB106 and DEFB107) as well as to DEFB4, DEFB103 and DEFB104, were found within two olive baboon (Papio cynocephalus anubis) draft genomic sequences (GenBank accession numbers AC116558 and AC116559) using BLAST. Full-length sequences were obtained for each baboon gene except the putative DEFB4 ortholog (which lacks a first exon because of gaps in the draft genomic sequences); in all other cases the exonic structure of the putative baboon ortholog was identical to that of the human gene (Figure 2). It is very likely that these sequences originate from the baboon locus orthologous to the human region under study, but without more complete sequence or mapping data for the baboon genome it is impossible to be certain. These novel baboon gene sequences (see Additional data files for the accession numbers), together with the published sequence for olive baboon beta-defensin 1 (AAK61474) and the full-length human beta-defensins formed the basis for our evolutionary analyses.
###end p 18
###begin p 19
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 16 18 16 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N </sub>
###xml 98 100 98 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 326 327 326 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N</sub>
###xml 330 332 330 332 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 337 339 337 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N </sub>
###xml 342 344 342 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 519 521 519 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 530 532 530 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N </sub>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 724 726 724 726 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 1013 1015 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 1039 1041 1039 1041 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N </sub>
###xml 1056 1057 1056 1057 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 1189 1191 1189 1191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N </sub>
###xml 1197 1199 1197 1199 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 1216 1222 1216 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 1226 1234 1226 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104 </italic>
###xml 1246 1254 1246 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB103 </italic>
###xml 1258 1265 1258 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107</italic>
###xml 1351 1352 1351 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1392 1394 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 292 297 <span type="species:ncbi:9606">human</span>
###xml 302 308 <span type="species:ncbi:9557">baboon</span>
###xml 657 662 <span type="species:ncbi:9606">human</span>
###xml 667 673 <span type="species:ncbi:9557">baboon</span>
###xml 1331 1337 <span type="species:ncbi:9557">baboon</span>
Figure 4 shows dN (number of nonsynonymous substitutions per nonsynonymous site) plotted against dS (number of synonymous substitutions per synonymous site) for comparisons between the first exon (which encodes the signal peptide) and second exon (which encodes the mature defensin) from all human and baboon genes (the full dN, dS and dN - dS estimates for all first and second exon comparisons are available as additional data file 7). Two major trends are observable. In the vast majority of first exon comparisons dS exceeds dN (Figure 4a) and this excess is statistically significant in almost every case according to two-tailed Z-test results for all human and baboon genes, but there were no significant excesses of dS according to the more rigorous Fisher's exact test (data not shown). Thus the rates of substitution in first exons indicate that they are evolving approximately neutrally, perhaps under weak purifying selection. The pattern seen in the second exon comparisons is quite different (Figure 4b). In the second exons dN often exceeds dS, and even in these short sequences, for certain comparisons this excess reaches statistical significance. Significant excesses of dN over dS are seen between DEFB1 and DEFB104 and between DEFB103 and DEFB107, with similar effects seen among the second exons of orthologous baboon genes (Table 1) using the method of Nei and Gojobori [20].
###end p 19
###begin p 20
###xml 32 34 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 101 103 101 103 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 697 704 697 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB103</italic>
###xml 706 714 706 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104 </italic>
###xml 718 726 718 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107 </italic>
###xml 796 798 796 798 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N </sub>
###xml 804 805 804 805 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 974 976 974 976 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 982 983 982 983 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N</sub>
Moreover, in these comparisons dS tends to be rather low relative to the rest of the data set (mean dS = 0.464). Similar results are obtained using this method either modified to take account of the transition-to-transversion ratio R [21] or using the Jukes-Cantor correction, although the unmodified method is thought to be a more reliable basis for the detection of positive selection [22]. If we assume that synonymous substitutions (which are selectively neutral or nearly so) have accumulated regularly with time, such a pattern of substitution suggests that duplication was followed by rapid nonsynonymous change that subsequently decelerated. Most comparisons involving the second exons of DEFB103, DEFB104 and DEFB107 with the second exons of other genes in the dataset show excesses of dN over dS, but these excesses fail to reach significance by either of the tests used (data not shown). Although some of the comparisons shown in Figure 4b indicate an excess of dS over dN, this is never significant by either of the two statistical tests used.
###end p 20
###begin p 21
###xml 196 203 196 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB103</italic>
###xml 205 212 205 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104</italic>
###xml 214 221 214 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105</italic>
###xml 223 231 223 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB106 </italic>
###xml 235 242 235 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107</italic>
###xml 473 475 473 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 573 580 573 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB103</italic>
###xml 582 590 582 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104 </italic>
###xml 594 602 594 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107 </italic>
###xml 739 741 733 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 983 985 971 973 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 1063 1065 1051 1053 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N </sub>
###xml 1078 1079 1066 1067 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 135 140 <span type="species:ncbi:9606">human</span>
###xml 145 151 <span type="species:ncbi:9557">baboon</span>
There is no detectable similarity between the introns of the genes under study except between the five putatively orthologous pairs of human and baboon genes where intronic sequence is available (DEFB103, DEFB104, DEFB105, DEFB106 and DEFB107): each pair shares 74-91% identity over 80-99% of their lengths in spite of many small indel events. In every case these pairs of orthologous introns show a substitution rate that is not significantly different from the value of dS obtained for the coding sequences. In particular, the orthologous intron sequence comparisons for DEFB103, DEFB104 and DEFB107 give substitution-rate estimates of 0.1066 +/- 0.010, 0.0816 +/- 0.005 and 0.0666 +/- 0.004 respectively, which are consistent with the dS estimates for the coding sequences of these pairs: 0.1666 +/- 0.077, 0.0856 +/- 0.058 and 0.0536 +/- 0.049. Thus, the excess of nonsynonymous substitutions observed for the second exons of these genes is not attributable to artificially low dS estimates as a result of sampling error, but is caused by a real increase in dN relative to dS, which is the pattern expected to be generated by positive selection.
###end p 21
###begin p 22
###xml 70 71 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 71 72 71 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 74 76 74 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink">C </sub>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 266 267 266 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Averages for the ratio of radical to conservative amino-acid changes, pR/pC calculated over 47 mammalian genes were reported as 0.81 and 0.49 for charge and the Miyata-Yasunaga (polarity and volume) classification respectively [23]. The equivalent values from Table 1, for comparisons between the second exons of genes showing evidence of positive selection, are all greater than these averages. Furthermore Table 1 shows that there has been a higher rate of change with respect to charge than with respect to polarity and volume (Miyata-Yasunaga amino-acid classification). That is, where there is evidence of positive selection, most nonsynonymous changes have tended to change the charges of the residues encoded but have tended to conserve the polarities and volumes of those residues.
###end p 22
###begin p 23
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 284 285 280 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N</sub>
###xml 287 288 283 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 998 1000 974 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1037 1046 1013 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB109p </italic>
###xml 1430 1432 1398 1400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1697 1699 1653 1655 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1741 1743 1697 1699 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1819 1821 1771 1773 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1907 1909 1855 1857 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 2092 2094 2036 2038 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 2796 2798 2724 2726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 3513 3515 3434 3436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
Likelihood ratio tests (LRTs), as implemented by the PAML package [24] also indicate the operation of positive selection at sites within second exons. These tests indicate whether data (the substitutions inferred from an alignment) are best explained by one of two models of omega = dN/dS. Since omega is a measure of selective pressure on proteins, these models can be used to assess the evidence for variable selective pressures among sites. In a test for positive selection (the presence of sites at which omega > 1) two statistical distributions are compared: a null model that uses a distribution that does not allow for sites with omega > 1 and another model which does allow such sites. Three pairs of site-specific likelihood models were compared that assume variable selective pressure (as determined by the value of omega) among sites but no variation among sequences in the dataset: M0 (one-ratio) and M3 (discrete), M1 (neutral) and M2 (selection), and M7 (beta) and M8 (beta + omega) [25]. The second exon of the pseudogene DEFB109p was omitted from the analysis. The discrete model (M3) with two site classes suggested that 41% of second-exon sites are under positive selection with omega= 1.67 and identified nine amino-acid sites under positive selection at the 95% cutoff. M3 was a significantly better fit to the data than the one-ratio model M0; the LRT statistic is 2Deltal = -1061.79-(-1004.12) = 115.32, and p < 0.001 with two degrees of freedom. However the M0-M3 comparison is essentially a test of variability in the omega ratio among sites and does not constitute a rigorous test of positive selection. Model M1 (neutral) assumes two site classes with omega = 0 and omega1 = 1 fixed and with the proportions p and p1 estimated. Model M2 (selection) adds a third site class with the ratio omega2 estimated, it suggests that about 47% of sites are under positive selection with omega2 = 53.17 and identified 12 amino-acid sites under positive selection at the 95% cutoff. The two models can be compared using an LRT as follows, 2Deltal = -1030.51 -(-1022.03) = 16.97; p < 0.001 with 2 df. So model M2 is significantly better than M1. Model M7 (beta) assumes a beta distribution for omega over sites. The beta distribution is limited to values between 0 and 1, providing the most flexible null hypothesis for testing positive selection. Model M8 (beta + omega) adds another site class to M7 (beta), with the omega ratio estimated from the data. However, the difference between M7 and M8 is not statistically significant, as indicated by the LRT: 2Deltal = -1006.44 -(-1006.44) = 0. Nine particular sites were implicated (in both M2 and M3 models) as being under positive selection with greater than 95% confidence: positions 43, 44, 48, 52, 56, 57, 69, 70 and 73 in Figure 2a. All these positions are close or adjacent to a conserved cysteine residue and so it is possible they are important in determining beta-defensin structure. In summary, the PAML analysis indicates that omega varies significantly between sites, and in two separate LRTs the parameters estimated suggest a substantial proportion of sites are under positive selection. In spite of this, the most stringent test (M7 versus M8) does not indicate a significant difference from neutrality. This result may be attributable to the extremely short lengths (33 codons aligned omitting positions with gaps) of the sequences aligned, such an effect was seen when analyzing short (130 codons) lysozyme sequences in the same way [25].
###end p 23
###begin title 24
Discussion
###end title 24
###begin p 25
###xml 145 152 142 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105</italic>
###xml 154 161 151 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB106</italic>
###xml 163 170 160 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107</italic>
###xml 172 179 169 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108</italic>
###xml 206 214 203 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB109p</italic>
###xml 556 561 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB4</italic>
###xml 563 571 557 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB103 </italic>
###xml 575 582 569 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104</italic>
###xml 1357 1363 1348 1354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 1430 1432 1421 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1701 1702 1688 1689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1703 1704 1690 1691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 265 271 <span type="species:ncbi:9557">baboon</span>
###xml 1261 1266 <span type="species:ncbi:9606">human</span>
###xml 1267 1273 <span type="species:ncbi:9557">baboon</span>
This study represents the most detailed study of a human beta-defensin cluster to date, including the full-length sequences of four novel genes (DEFB105, DEFB106, DEFB107, DEFB108), and a novel pseudogene (DEFB109p), their expression patterns and sequences for the baboon orthologs of six genes from this cluster. The 8p22-23 defensin locus appears to have evolved by successive rounds of duplication followed by substantial divergence, to produce a diverse cluster of paralogous genes defined by these four novel genes and four known beta-defensin genes (DEFB4, DEFB103 and DEFB104). Divergence has been most rapid within the second exons of these genes, which encode the mature beta-defensin peptide, with many comparisons between paralogous genes showing an excess of nonsynonymous over synonymous substitutions. Statistically significant evidence of elevated nonsynonymous change is seen by two methods in the second exons, indicating the action of positive selection. By contrast, comparisons between the first exons of genes from this cluster, which encode a signal peptide, show an excess of synonymous substitutions consistent with neutral evolution or weak purifying selection. The duplication and subsequent positive selection of these genes predates human-baboon divergence more than 23 million years ago and is consistent with observations that DEFB1 has undergone very little change during the evolution of primates [11]. The positive selection observed has tended to change the charges of residues encoded more than other qualities such as residue polarity or volume. As seems to be the case with other antimicrobial peptides, such as MHC receptors, immunoglobulins and alpha-defensins [6-8], this selection may be a response to the rapid evolution of pathogens.
###end p 25
###begin p 26
###xml 500 505 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 508 509 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
In this study the computationally predicted gene structures were found by laboratory work to deviate from the actual structures in three out of five novel genes. These errors in the predictions arose in spite of the fact that the predictions were based on all the beta-defensin protein-sequence data available and involved three completed BAC sequences rather than unfinished, gapped sequence. This has implications for purely computational approaches to novel gene discovery such as that of Schutte et al. [4].
###end p 26
###begin p 27
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104 </italic>
###xml 12 20 12 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108 </italic>
###xml 495 503 492 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104 </italic>
###xml 638 640 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 779 781 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 846 851 840 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1</italic>
###xml 853 859 847 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB4 </italic>
###xml 863 870 857 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB103</italic>
###xml 873 881 867 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104 </italic>
###xml 1025 1033 1019 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104 </italic>
###xml 1081 1104 1075 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas aeruginosa </italic>
###xml 1174 1176 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1220 1227 1211 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105</italic>
###xml 1229 1237 1220 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB106 </italic>
###xml 1241 1248 1232 1239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108</italic>
###xml 1343 1351 1334 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104 </italic>
###xml 1566 1574 1554 1562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107 </italic>
###xml 1728 1733 1713 1718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Defr1</italic>
###xml 1850 1852 1835 1837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1889 1895 1874 1880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 2070 2072 2055 2057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 2467 2469 2446 2448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 2769 2771 2742 2744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 2798 2804 2768 2774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Defb2 </italic>
###xml 3084 3091 3054 3061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 3196 3198 3163 3165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
###xml 824 829 <span type="species:ncbi:9606">human</span>
###xml 1081 1103 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 1523 1528 <span type="species:ncbi:9606">human</span>
###xml 1529 1535 <span type="species:ncbi:9557">baboon</span>
###xml 1658 1664 <span type="species:ncbi:9557">baboon</span>
###xml 1702 1707 <span type="species:ncbi:10090">mouse</span>
###xml 2623 2628 <span type="species:ncbi:9606">human</span>
###xml 2633 2638 <span type="species:ncbi:10090">mouse</span>
###xml 2778 2783 <span type="species:ncbi:10090">mouse</span>
DEFB104 and DEFB108 have no detectable orthologs in the mouse genome and therefore appear to have arisen by duplication since the divergence of rodents and primates; alternatively, there could have been a loss of these genes in the rodent lineage. They are also the best candidates for primate-specific beta-defensins as they lack orthologs within all other known mammalian defensins, although our knowledge of mammalian defensins is currently incomplete. As we have shown, the evolution of the DEFB104 mature peptide has been driven by positive selection since its emergence, which is consistent with its novel antimicrobial properties [26]. All defensins were thought to exist as monomers stabilized by three disulfide bridges between their three pairs of conserved cysteines [19]. However, when compared with other known human beta-defensins (DEFB1, DEFB4 and DEFB103), DEFB104 was found to have a different number of residues between its second and third, and between its fourth and fifth cysteine residues. Furthermore, DEFB104 was found to have bactericidal activity against Pseudomonas aeruginosa that was more than sixfold stronger than for any other beta-defensin [26]. Three of the novel genes described here (DEFB105, DEFB106 and DEFB108) encode mature peptides exhibiting the same spacing of conserved cysteine residues as seen in DEFB104 as well as sharing similar expression patterns, with highest expression in the testes. The functional divergence of beta-defensin genes appears to have continued following human-baboon divergence, as exemplified by DEFB107 which displays a serine residue instead of the first canonical cysteine seen in the baboon ortholog. It is notable that a novel mouse beta-defensin gene (Defr1), which also lacks the first canonical cysteine, has potent antimicrobial activity against a spectrum of pathogens [27]. In addition a polymorphism in the DEFB1 gene which alters the first canonical cysteine to a serine residue has been shown to produce a peptide which is as active against the microorganisms tested as the usual form [28]. The unusual amino-acid composition of the proteins encoded by the novel genes presented here suggests that they may possess novel functions, indeed the cationic nature of beta-defensins is lost in DEFB107 and DEFB108. As shown recently, there may be more subtle consequences of variation in beta-defensin protein sequences, affecting dimerization as well as net charge and disulfide bridges [29]. It is worth noting that recent research has identified additional functions for beta-defensins that link the innate and adaptive immune response. Both human and mouse beta-defensins have been shown to be chemotactic for immature dendritic cells and memory T cells via the CCR6 chemokine receptor [30]. The mouse beta-defensin Defb2 has been shown to act directly on immature dendritic cells as an endogenous ligand for Toll-like receptor 4 (TLR-4), inducing upregulation of co-stimulatory molecules and dendritic cell maturation. These events, in turn, trigger robust, type-1 polarized adaptive immune responses in vivo, which suggests that beta-defensins may have an important role in immunosurveillance against pathogens [31].
###end p 27
###begin p 28
###xml 251 257 244 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 334 336 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 384 391 377 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105</italic>
###xml 393 400 386 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB106</italic>
###xml 402 410 395 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107 </italic>
###xml 414 422 407 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108 </italic>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 245 250 <span type="species:ncbi:9606">human</span>
The expression of the novel antimicrobial peptides reported here in the human male reproductive tract is also of interest. Recent work has shown that the male urogenital tracts in mammals express a broad range of alpha- and beta-defensins, with human DEFB1 expressed in testicular biopsies, seminal plasma and ejaculated spermatozoa [32]. Together with our results demonstrating that DEFB105, DEFB106, DEFB107 and DEFB108 are predominantly expressed in the testes, these data suggest that the male reproductive tract has a complex innate defense mechanism.
###end p 28
###begin title 29
Conclusions
###end title 29
###begin p 30
###xml 164 171 161 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105</italic>
###xml 173 180 170 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB106</italic>
###xml 182 189 179 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107</italic>
###xml 191 198 188 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108</italic>
###xml 221 229 218 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB109p</italic>
###xml 255 260 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB4</italic>
###xml 262 270 259 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB103 </italic>
###xml 274 281 271 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104</italic>
###xml 405 411 <span type="species:ncbi:9557">baboon</span>
###xml 511 516 <span type="species:ncbi:9606">human</span>
The 8p22-23 beta-defensin locus has evolved by duplication and subsequent divergence, to produce a diverse cluster of paralogous genes defined by four novel genes (DEFB105, DEFB106, DEFB107, DEFB108), a novel pseudogene (DEFB109p), and three known genes (DEFB4, DEFB103 and DEFB104). We present full-length sequences for the four novel genes, their expression patterns and the predicted sequences for the baboon orthologs of six genes from this cluster. Although comparisons among first-exon sequences of these human genes show little variation, the second-exon sequences that encode the mature beta-defensin peptides show substantial divergence. Evolutionary analyses suggest that the divergence seen in second exons has involved positive selection disproportionately favoring alterations in the charge of amino-acid residues.
###end p 30
###begin title 31
Materials and methods
###end title 31
###begin title 32
Identification of novel genes
###end title 32
###begin p 33
###xml 358 364 343 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 374 380 359 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB4 </italic>
###xml 390 398 375 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB103 </italic>
###xml 411 419 396 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104 </italic>
###xml 436 454 421 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rattus norvegicus </italic>
###xml 514 525 493 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bos taurus </italic>
###xml 1012 1023 946 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sus scrofa </italic>
###xml 1055 1068 986 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Capra hircus </italic>
###xml 1129 1140 1054 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ovis aries </italic>
###xml 1207 1222 1126 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Macaca mulatta </italic>
###xml 1290 1316 1203 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pabio cynocephalus anubis </italic>
###xml 1356 1372 1266 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pan troglodytes </italic>
###xml 1531 1533 1432 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1705 1707 1606 1608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1767 1769 1668 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1917 1919 1818 1820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 77 82 <span type="species:ncbi:10090">Mouse</span>
###xml 351 356 <span type="species:ncbi:9606">Human</span>
###xml 431 434 <span type="species:ncbi:10116">Rat</span>
###xml 436 453 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 509 512 <span type="species:ncbi:9913">Cow</span>
###xml 514 524 <span type="species:ncbi:9913">Bos taurus</span>
###xml 1007 1010 <span type="species:ncbi:9823">Pig</span>
###xml 1012 1022 <span type="species:ncbi:9823">Sus scrofa</span>
###xml 1049 1053 <span type="species:ncbi:9925">Goat</span>
###xml 1055 1067 <span type="species:ncbi:9925">Capra hircus</span>
###xml 1122 1127 <span type="species:ncbi:9940">Sheep</span>
###xml 1129 1139 <span type="species:ncbi:9940">Ovis aries</span>
###xml 1192 1205 <span type="species:ncbi:9544">Rhesus monkey</span>
###xml 1207 1221 <span type="species:ncbi:9544">Macaca mulatta</span>
###xml 1276 1288 <span type="species:ncbi:9555">Olive baboon</span>
###xml 1344 1354 <span type="species:ncbi:9598">Chimpanzee</span>
###xml 1356 1371 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 1892 1897 <span type="species:ncbi:9606">human</span>
The following mammalian beta-defensin sequences were retrieved from GenBank. Mouse beta-defensins: 1-11 (NP_031869, NP_034160, NP_038784, NP_062702, NP_109659, NP_473415, NP_631966, CAC44635, NP_631965, CAD26894, CAD26895), beta-defensin 13 (NP_631969), beta-defensin 15 (NP_631970), beta-defensin 35 (NP_631970), defensin-related peptide (AJ344114). Human: DEFB1 (Q09753), DEFB4 (O15263), DEFB103 (NP_061131), DEFB104 (CAC85520). Rat: Rattus norvegicus beta-defensin 1 (NP_113998), beta-defensin 2 (O88514). Cow: Bos taurus beta-defensin 1 (P46159), beta-defensin 2 (P46160), beta-defensin 3 (P46161), beta-defensin 4 (P46162), beta-defensin 5 (P46163), beta-defensin 6 (P46164), beta-defensin 7 (P46165), beta-defensin 8 (P46166), beta-defensin 9 (P46167), beta-defensin 10 (P46168), beta-defensin 11 (P46169), beta-defensin 12 (P46170), beta-defensin 13 (P46171), tracheal antimicrobial peptide (P25068), lingual antimicrobial peptide (Q28880), enteric beta-defensin (O02775), beta-defensin C7 (O18815). Pig: Sus scrofa beta-defensin 1 (O62697). Goat: Capra hircus beta-defensin 1 (O97946), beta-defensin 2 (CAA08905). Sheep: Ovis aries beta-defensin 1 (O19038), beta-defensin 2 (O19039). Rhesus monkey: Macaca mulatta beta-defensin 1 (O18794), beta-defensin 2 (AAK26259). Olive baboon: Pabio cynocephalus anubis beta-defensin 1 (AAK61474). Chimpanzee: Pan troglodytes beta-defensin 1 (AAF04110), beta-defensin 2 (AAF20154), beta-defensin 3 (AAK61549). These sequences were used as TBLASTX (version 2.1.1 with default settings [12]) queries against the HTG (high-throughput genomic) section of the EMBL database (15 July 2001 release). Hidden Markov models were constructed using HMMER (version 2.1.1 [33]) to process CLUSTALW (version 1.82 with default settings [34]) multiple sequence alignments. These models were searched against genomic sequence using WISE2 (version 2-1-20c with the human gene model option [35]). CLUSTALW alignments of diverse second-exon sequences were corrected using the patterns of gaps seen in the corresponding protein-sequence alignments that were more highly conserved.
###end p 33
###begin title 34
Evolutionary analyses
###end title 34
###begin p 35
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 254 260 254 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GGGAL1</italic>
###xml 469 470 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 543 544 543 544 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N</sub>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 931 933 931 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 938 939 938 939 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N</sub>
###xml 962 964 962 964 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 969 971 969 971 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N </sub>
###xml 1040 1042 1040 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 1047 1049 1047 1049 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N </sub>
###xml 1146 1148 1146 1148 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N </sub>
###xml 1151 1153 1151 1153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 1158 1160 1158 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1318 1320 1318 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1432 1434 1432 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1516 1517 1516 1517 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N</sub>
###xml 1519 1521 1519 1521 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 1582 1587 1582 1587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1590 1592 1590 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1758 1760 1754 1756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1861 1863 1857 1859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1977 1979 1973 1975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 2139 2141 2135 2137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 2246 2248 2242 2244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 2451 2453 2447 2449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 232 239 <span type="species:ncbi:9031">chicken</span>
All phylogenetic trees were constructed by the neighbour-joining method [36] based on the proportion of amino-acid sites at which sequences compared were different and omitting alignment gaps. The trees constructed were rooted with chicken gallinacin 1 (GGGAL1; P46156) and the reliability of each branch was assessed using 1,000 bootstrap replications. In pairwise comparisons between nucleotide sequences, the number of synonymous substitutions per synonymous site (dS) and the number of nonsynonymous substitutions per nonsynonymous site (dN) were estimated using the method of Nei and Gojobori [20], modified to take account of the transition-to-transversion ratio R [21]. R was estimated using the method of Kumar and Nei [22]. In addition, the Jukes-Cantor correction [37] was applied to account for multiple substitutions at the same site. Two codon-based tests of selection were used. Both tests are based on estimates of dS and dN. Standard errors for dS and dN were calculated using 1,000 bootstrap replicates. In the first test dS and dN and their respective variances are used in a two-tailed Z-test to test the null hypothesis that dN - dS = 0 [21]. In the second test, Fisher's exact test is used to test the null hypothesis that the proportions of synonymous and nonsynonymous differences are the same [38]. Additional tests for the presence of sites under positive selection were carried out using the PAML package [24], which uses likelihood ratio tests (LRT) to compare models of the variation in dN/dS ratio between sites. The six models recommended by Anisimova et al. [39] were tested: M0 (one-ratio), M1 (neutral), M2 (selection), M3 (discrete), M7 (beta), and M8 (beta+omega). Intron sequences were aligned using DIALIGN (version 2.1 [40]) and the numbers of substitutions between them were estimated using Kimura's two-parameter method [41]. All phylogenetic trees, distance calculations and codon-based tests of selection were carried out using MEGA2 [42]. Estimates of the proportions of radical and conservative nonsynonymous substitutions, along with their standard errors, were made using the HON-NEW program [23] in an extension of earlier methods for the measurement of conservative and radical substitution rates [43]. The radical or conservative nature of nonsynonymous substitutions was assessed with respect to charge and to the polarity and volume of the amino acids (the Miyata-Yasunaga amino-acid classification [44]).
###end p 35
###begin title 36
RT-PCR analysis of gene expression
###end title 36
###begin p 37
###xml 1632 1634 1602 1604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1709 1716 1679 1686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105</italic>
###xml 1828 1835 1798 1805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB106</italic>
###xml 1941 1948 1911 1918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107</italic>
###xml 2055 2062 2025 2032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108</italic>
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 213 218 <span type="species:ncbi:9606">human</span>
A range of human RNA samples was purchased from Stratagene (Amsterdam, The Netherlands) (stomach, vulva, ovary, kidney, placenta, thyroid, lung, skeletal, uterus, breast, liver, skin, colon, heart and cervix) and human testis RNA (BD Biosciences Clontech, Oxford). cDNA synthesis was carried out using a first-strand cDNA synthesis kit (Roche, Lewes, UK) according to the instructions, using random hexameric oligonucleotides. PCRs were carried out, using 5 ml of the resultant cDNA according to the following procedures: 94degreesC for 1 min followed by 35 cycles of 94degreesC for 30 sec, 55degreesC for 30 sec and 72degreesC for 1 min, and a final round of extension for 5 min. Products were analyzed on a 4% NuSIEVE agarose gel (FMC BioProducts, Rockland, ME, USA) by electrophoresis and also cloned using pGEM-T Easy Vector System I (Promega, Southampton). Amplification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was carried out in parallel with conditions as for the other amplifications, but with an annealing temperature of 56degreesC. Reactions were verified for RNA amplification by including controls without reverse transcriptase. RT-PCR products were hybridized with a radiolabeled, internal oligonucleotide probe designed to each novel sequence to confirm the presence of the correctly amplified product. Purified plasmid DNA was sequenced from both strands with ABI Prism dRhodamine Terminator Cycle Sequencing Ready Reaction Kit (PE Applied Biosystems, Warrington). Primers and internal probes were designed using the Primer3 primer design program from the Whitehead Institute, Center for Genome Research [45]. The sequences for the primers and internal probes used were as follows: DEFB105: 5' primer: TCTATTTGCTATGTTCTTCATTTTGG, internal oligo: TTCAACTGCCATCAGGTGAG, 3' primer: GCAGCAGAGAAAGTTCAGCC; DEFB106: 5' primer: CGTGCTCTTCTTTCTGACCC, internal oligo: TACAGGGAAGGTGATCGGAG, 3' primer: GTTCTTCATTTTTCCCGCAA; DEFB107: 5' primer: TTTTGGCTGCTCTCATTCTTC, internal oligo: TCACTGTGAAGCCGAATGTC, 3' primer: TGCAGCAAAATGGTGCTAAT; DEFB108: 5' primer: TGCTGTCCTCTTCTTCACCA, internal oligo: GCCAAGTTCTACCAGCCAAG, 3' primer: CGGCTATTTAAACATCTCCCA.
###end p 37
###begin p 38
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105</italic>
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB106</italic>
###xml 53 60 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107</italic>
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108 </italic>
###xml 74 82 74 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB109p</italic>
###xml 281 287 281 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB4 </italic>
###xml 307 314 307 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB103</italic>
###xml 316 323 316 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB104</italic>
###xml 325 332 325 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105</italic>
###xml 334 342 334 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB106 </italic>
###xml 346 354 346 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107 </italic>
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 251 257 <span type="species:ncbi:9557">baboon</span>
###xml 275 280 <span type="species:ncbi:9606">human</span>
The novel human gene sequences for DEFB105, DEFB106, DEFB107, DEFB108 and DEFB109p, as confirmed by RT-PCR, have been deposited in GenBank under sequence accession numbers AF540977, AF540978, AF540979, AF540980 and AF540981 respectively. The putative baboon orthologs of the human DEFB4 (second exon only), DEFB103, DEFB104, DEFB105, DEFB106 and DEFB107 genes have been also been deposited in GenBank under sequence accession numbers BK000556, BK000557, BK000558, BK000559, BK000560 and BK000561 respectively.
###end p 38
###begin title 39
Additional data files
###end title 39
###begin p 40
###xml 125 126 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="s1">1</xref>
###xml 194 195 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="s2">2</xref>
###xml 263 264 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="s3">3</xref>
###xml 343 344 337 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="s4">4</xref>
###xml 424 425 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="s5">5</xref>
###xml 500 501 494 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="s6">6</xref>
###xml 657 658 651 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="s7">7</xref>
###xml 753 755 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 75 87 <span type="species:ncbi:9555">olive baboon</span>
###xml 151 156 <span type="species:ncbi:9606">human</span>
###xml 210 216 <span type="species:ncbi:9557">baboon</span>
###xml 221 226 <span type="species:ncbi:9606">human</span>
###xml 290 296 <span type="species:ncbi:9557">baboon</span>
###xml 301 306 <span type="species:ncbi:9606">human</span>
###xml 371 377 <span type="species:ncbi:9557">baboon</span>
###xml 382 387 <span type="species:ncbi:9606">human</span>
###xml 453 459 <span type="species:ncbi:9557">baboon</span>
###xml 464 469 <span type="species:ncbi:9606">human</span>
The following files are available with this article: the DNA sequences for olive baboon beta-defensins (Additional data file 1), the DNA sequences for human beta-defensins (Additional data file 2), the aligned baboon and human DNA sequences (Additional data file 3), the aligned first-exon baboon and human DNA sequences (Additional data file 4), the aligned second-exon baboon and human DNA sequences (Additional data file 5) and the DNA sequences for baboon and human introns (Additional data file 6) and an Excel file listing the full dN, dS and dN - dS estimates for all first and second exon comparisons shown in Figures 4a and b (Additional data file 7). The alignments are in MSF format. The sequence and alignment files are also available from [46].
###end p 40
###begin title 41
Supplementary Material
###end title 41
###begin title 42
Additional data file 1
###end title 42
###begin p 43
###xml 22 34 <span type="species:ncbi:9555">olive baboon</span>
The DNA sequences for olive baboon beta-defensins
###end p 43
###begin p 44
Click here for additional data file
###end p 44
###begin title 45
Additional data file 2
###end title 45
###begin p 46
###xml 22 27 <span type="species:ncbi:9606">human</span>
The DNA sequences for human beta-defensins
###end p 46
###begin p 47
Click here for additional data file
###end p 47
###begin title 48
Additional data file 3
###end title 48
###begin p 49
###xml 12 18 <span type="species:ncbi:9557">baboon</span>
###xml 23 28 <span type="species:ncbi:9606">human</span>
The aligned baboon and human DNA sequences in MSF format
###end p 49
###begin p 50
Click here for additional data file
###end p 50
###begin title 51
Additional data file 4
###end title 51
###begin p 52
###xml 23 29 <span type="species:ncbi:9557">baboon</span>
###xml 34 39 <span type="species:ncbi:9606">human</span>
The aligned first-exon baboon and human DNA sequences in MSF format
###end p 52
###begin p 53
Click here for additional data file
###end p 53
###begin title 54
Additional data file 5
###end title 54
###begin p 55
###xml 24 30 <span type="species:ncbi:9557">baboon</span>
###xml 35 40 <span type="species:ncbi:9606">human</span>
The aligned second-exon baboon and human DNA sequences in MSF format
###end p 55
###begin p 56
Click here for additional data file
###end p 56
###begin title 57
Additional data file 6
###end title 57
###begin p 58
###xml 22 28 <span type="species:ncbi:9557">baboon</span>
###xml 33 38 <span type="species:ncbi:9606">human</span>
The DNA sequences for baboon and human introns
###end p 58
###begin p 59
Click here for additional data file
###end p 59
###begin title 60
Additional data file 7
###end title 60
###begin p 61
###xml 10 11 10 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N</sub>
###xml 14 15 14 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 21 22 21 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N</sub>
###xml 26 27 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
The full dN, dS and dN - dS estimates for all first and second exon comparisons shown in Figures 4a and b
###end p 61
###begin p 62
Click here for additional data file
###end p 62
###begin title 63
Acknowledgements
###end title 63
###begin p 64
This work benefited from the financial support of the UK Medical Research Council. We would also like to thank Gillian Morrison for her initial involvement in this project.
###end p 64
###begin article-title 65
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis.
###end article-title 65
###begin article-title 66
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human beta-defensin-2.
###end article-title 66
###begin article-title 67
Defensins of vertebrate animals.
###end article-title 67
###begin article-title 68
Discovery of five conserved beta-defensin gene clusters using a computational search strategy.
###end article-title 68
###begin article-title 69
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB4 </italic>
###xml 33 38 <span type="species:ncbi:9606">human</span>
Expression and regulation of the human beta-defensins DEFB1 and DEFB4 in intestinal epithelium.
###end article-title 69
###begin article-title 70
Evolution of vertebrate immunoglobulin variable gene segments.
###end article-title 70
###begin article-title 71
Natural selection at major histocompatibility complex loci of vertebrates.
###end article-title 71
###begin article-title 72
Coordinated amino acid changes in the evolution of mammalian defensins.
###end article-title 72
###begin article-title 73
Evolutionary diversification of the mammalian defensins.
###end article-title 73
###begin article-title 74
Roles of diversifying selection and coordinated evolution in the evolution of amphibian antimicrobial peptides.
###end article-title 74
###begin article-title 75
###xml 43 48 <span type="species:ncbi:9606">human</span>
Beta-defensin 1 gene variability among non-human primates.
###end article-title 75
###begin article-title 76
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
###end article-title 76
###begin article-title 77
Genome Sequencing Center, Washington University in St. Louis.
###end article-title 77
###begin article-title 78
RepeatMasker
###end article-title 78
###begin article-title 79
Multiple promoter and splicing mRNA variants of the epididymis-specific gene EP2.
###end article-title 79
###begin article-title 80
The Ensembl genome database project.
###end article-title 80
###begin article-title 81
###xml 5 10 <span type="species:ncbi:9606">Human</span>
HUGO Human Gene Nomenclature Committee
###end article-title 81
###begin article-title 82
Genotype-phenotype correlation in cystic fibrosis: The role of modifier genes.
###end article-title 82
###begin article-title 83
Structure, function, and membrane integration of defensins.
###end article-title 83
###begin article-title 84
Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions.
###end article-title 84
###begin article-title 85
Positive Darwinian selection after gene duplication in primate ribonuclease genes.
###end article-title 85
###begin article-title 86
Rates of conservative and radical nonsynonymous nucleotide substitutions in mammalian nuclear genes.
###end article-title 86
###begin article-title 87
PAML: a program package for phylogenetic analysis by maximum likelihood.
###end article-title 87
###begin article-title 88
Codon-substitution models for detecting molecular adaptation at individual sites along specific lineages.
###end article-title 88
###begin article-title 89
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity.
###end article-title 89
###begin article-title 90
###xml 47 53 <span type="species:ncbi:10090">murine</span>
Identification and characterisation of a novel murine beta-defensin related gene.
###end article-title 90
###begin article-title 91
###xml 85 91 85 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB1 </italic>
Structural and functional characterization of hBD-1(Ser35), a peptide deduced from a DEFB1 polymorphism.
###end article-title 91
###begin article-title 92
###xml 135 156 135 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 135 156 <span type="species:ncbi:1280">Staphylococcus aureus</span>
The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus.
###end article-title 92
###begin article-title 93
Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6.
###end article-title 93
###begin article-title 94
Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.
###end article-title 94
###begin article-title 95
###xml 72 76 <span type="species:ncbi:10116">rats</span>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 88 94 <span type="species:ncbi:9606">humans</span>
Expression of antimicrobial defensins in the male reproductive tract of rats, mice, and humans.
###end article-title 95
###begin article-title 96
Profile hidden Markov models.
###end article-title 96
###begin article-title 97
Using CLUSTALW for multiple sequence alignments.
###end article-title 97
###begin article-title 98
WISE2
###end article-title 98
###begin article-title 99
The neighbor-joining method: a new method for reconstructing phylogenetic trees.
###end article-title 99
###begin article-title 100
Evolution of protein molecules.
###end article-title 100
###begin article-title 101
Small-sample tests of episodic adaptive evolution: a case study of primate lysozymes.
###end article-title 101
###begin article-title 102
Accuracy and power of bayes prediction of amino acid sites under positive selection.
###end article-title 102
###begin article-title 103
DIALIGN 2: improvement of the segment-to-segment approach to multiple sequence alignment.
###end article-title 103
###begin article-title 104
A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences.
###end article-title 104
###begin article-title 105
MEGA2: molecular evolutionary genetics analysis software.
###end article-title 105
###begin article-title 106
Positive Darwinian selection promotes charge profile diversity in the antigen-binding cleft of class I major-histocompatibility-complex molecules.
###end article-title 106
###begin article-title 107
Two types of amino acid substitutions in protein evolution.
###end article-title 107
###begin article-title 108
Primer3
###end article-title 108
###begin article-title 109
MRC HGU Semple lab: data/software
###end article-title 109
###begin title 110
Figures and Tables
###end title 110
###begin p 111
###xml 57 61 54 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 121 128 115 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB105</italic>
###xml 130 137 124 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB106</italic>
###xml 139 146 133 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB107</italic>
###xml 148 156 142 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB108 </italic>
###xml 160 169 154 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB109p </italic>
###xml 757 761 751 755 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 707 713 <span type="species:ncbi:9557">baboon</span>
###xml 795 800 <span type="species:ncbi:9606">human</span>
###xml 923 930 <span type="species:ncbi:9031">chicken</span>
Genomic organization of novel human beta-defensin genes. (a) The genomic organization of novel human beta-defensin genes DEFB105, DEFB106, DEFB107, DEFB108 and DEFB109p on 8p22-p23. The horizontal lines represent the three BAC clones in which all novel genes were found. Exons are represented as triangles with the vertical side representing the position of the exon. Exons above the horizontal lines are transcribed from the strand represented by the original BAC clone sequence entries whereas those below are transcribed in the opposite direction from the complementary strand. The region depicted is about 350 kb centromeric of DEFB1. Those genes marked with an asterisk were found to have orthologs in baboon genomic sequences (AC116558 and AC116559). (b) A phylogenetic tree of functional human beta-defensins using the prepropeptide sequences encoded by the genes shown in (a). The phylogenetic tree was rooted with chicken gallinacin 1 (GGGAL1; P46156) and the reliability of each branch was assessed using 1,000 bootstrap replications.
###end p 111
###begin p 112
###xml 0 4 0 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 18 22 18 22 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 939 947 936 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DEFB109p</italic>
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 53 59 <span type="species:ncbi:9557">baboon</span>
###xml 118 125 <span type="species:ncbi:9031">chicken</span>
(a) Alignment and (b) phylogenetic tree of human and baboon beta-defensin protein sequences. The tree was rooted with chicken gallinacin 1 (GGGAL1; P46156) and the reliability of each branch was assessed using 1,000 bootstrap replications. The alignment shows the same sequences with the estimated locations of the signal peptide and mature peptide regions; the intervening region is the propiece. The long arrow indicates the position of first introns: in each case except DEFB105 the intron splits the codon that encodes the residue immediately before the arrow. The short arrow indicates the second intron, found only in DEFB105. The shading represents the degree of conservation at each position in the alignment, taking into account similar physicochemical properties of residues. The six canonical cysteines are indicated under the appropriate alignment positions. X at residue 14 denotes the location of the premature stop codon in DEFB109p.
###end p 112
###begin p 113
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 129 134 <span type="species:ncbi:9606">human</span>
Expression patterns of novel human beta-defensin genes. RT-PCR analysis of novel human gene expression carried out on a panel of human RNA samples. The tissues are indicated with a plus (+) and a minus (-) reverse transcriptase reaction shown for each sample. GAPDH RT-PCR was carried out as a control.
###end p 113
###begin p 114
###xml 158 159 158 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 236 237 236 237 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N</sub>
###xml 263 267 263 267 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 287 291 287 291 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 376 378 376 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N </sub>
###xml 381 382 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
The rates of synonymous and nonsynonymous substitutions within first and second exons. Graphs of the number of synonymous substitutions per synonymous site (dS) against the number of nonsynonymous substitutions per nonsynonymous site (dN) for comparisons between (a) the first exons and (b) second exons of all genes in the dataset. In each case the diagonal line represents dN = dS.
###end p 114
###begin p 115
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 61 67 <span type="species:ncbi:9557">baboon</span>
Results of comparisons between the second exons of human and baboon genes demonstrating positive selection
###end p 115
###begin p 116
###xml 233 234 233 234 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 307 308 307 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N</sub>
###xml 311 317 311 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224;</sup>
###xml 355 357 350 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink">N </sub>
###xml 360 362 355 357 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 367 380 362 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8225;</sup>
###xml 417 429 400 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#167;</sup>
###xml 447 448 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 448 449 420 421 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 469 470 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 470 471 442 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink">C</sub>
###xml 558 559 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 559 560 531 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 561 562 533 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 562 563 534 535 <sub xmlns:xlink="http://www.w3.org/1999/xlink">C</sub>
###xml 617 631 589 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#182;</sup>
###xml 631 632 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 632 634 591 593 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R </sub>
###xml 664 665 623 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 665 666 624 625 <sub xmlns:xlink="http://www.w3.org/1999/xlink">C</sub>
###xml 668 669 627 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
###xml 687 688 646 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 688 689 647 648 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 709 710 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 710 711 669 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink">C</sub>
###xml 798 799 757 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 799 800 758 759 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 801 802 760 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 802 803 761 762 <sub xmlns:xlink="http://www.w3.org/1999/xlink">C</sub>
*Estimates (6SE) of the number of synonymous sites (S), number of nonsynonymous sites, numbers of synonymous substitutions (s), numbers of nonsynonymous substitutions (n), the number of synonymous substitutions per synonymous site (dS) and the number of nonsynonymous substitutions per nonsynonymous site (dN). daggerThe result of a two-tailed Z-test of dN - dS = 0. double daggerThe result of a Fisher's exact test. section signRates of radical (pR) and conservative (pC) changes in amino-acid properties, with the ratio of radical to conservative changes (pR/pC) for residues categorized in terms of their charges. paragraph signpR is significantly greater than pC. #Rates of radical (pR) and conservative (pC) changes in amino-acid properties, with the ratio of radical to conservative changes (pR/pC) for residues categorized in terms of the Miyata-Yasunaga classification (M-Y; a combination of polarity and volume).
###end p 116

